Investor Presentaiton
Manager Overview (Future Generations Fund)
Fund Manager
Lead Portfolio Manager
Region of
Domicile
Date of Fund
Inception
2017
Returns
NSIA's
NAV
$(min)
NSIA
Inception
African Capital
Alliance Private
Equity IV
Paul Kokoricha & Cyril Odu
Lagos, Nigeria
N/A
-20.69%
Secondary
Private Equity:
KG Brussels
16 Fund Holdings:
Avenue Special Situations Fund IV, L.P.
• Cerberus Institutional Partners, L.P. Series Four
• Fortress Investment Fund IV, L.P.
• Fortress Investment Fund IV Coinvestment, L.P.
• Fortress Investment Fund V, L.P.
• Fortress Investment Fund V Coinvestment, L.P.
• H.I.G. Bayside Opportunity Fund, L.P.
Marlin Equity, L.P.
• Marlin Equity II, L.P.
• OCM Opportunities Fund IVb, L.P.
OCM Opportunities Fund VI, L.P.
• OCM Opportunities Fund VII, L.P.
• OCM Opportunities Fund VIIb, L.P.
•Sun Capital Partners IV, LP
•Wayzata Opportunities Fund, LLC
•Wayzata Opportunities Fund II, L.P.
3.2
32
Fund Strategy
Nigeria
Sovereign
Investment
Authority
Fund Logo
15-Nov-2015
ACA was founded in 1997
under the leadership of Okey
Enelamah and Dick Kramer.
With more than 15 years of
investing experience in
Nigerian private equity, ACA
benefits from its strong brand
name and deep connections.
ACA maintains flexibility to
invest in buyout and growth
equity deals in companies of
various enterprise values and
avoids companies subject to
competitive
auction
processes. Fund IV has
targeted $600m to invest
across West Africa, seeking a
3.0x multiple and a 30% IRR.
A
Abuja, Nigeria
15-Aug-2014
N/A
47.9
Healthcare Royalty
Gregory B. Brown & Todd C. Davis
Stamford, U.S.A.
2007
N/A
0.3
Partners III
15-Aug-2014
NSIA created this vehicle for
transactional and tax
efficiency purposes relating to
the acquisition of a portfolio of
private equity interests from a
European
banking
counterparty. This portfolio has
performed exceptionally well
both in terms of cash
distributions and in terms the
absolute revaluation gain. It is
expected that 99% of the
portfolio will be liquidated by
year end 2018.
KGBrussels.P
15-Aug-2014
HCRP was founded in 2007 by the
royalty team formerly at Paul
Capital. Healthcare royalties offer
high yield (low- to mid-teens,
thereby mitigating the J-curve
effect) with downside protection in
the form of capital structure
seniority. Returns are linked to
healthcare product sales, which
are generally stable and exhibit low
correlation with other asset classes.
Fund III has raised $1.5bn and is
targeting a 1.6-2.0x multiple and a
gross IRR of 15-18%.
HEALTHCARE
ROYALTY PARTNERS™
54
....View entire presentation